Manida Suksawat, Manida Suksawat, Manida Suksawat, Jutarop Phetcharaburanin, Jutarop Phetcharaburanin, Jutarop Phetcharaburanin, . . . Watcharin Loilome. (2022). Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. Frontiers Media S.A..
Chicago Style (17th ed.) CitationManida Suksawat, et al. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationManida Suksawat, et al. Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.